| Revenue Growth | Gap co-location revenue increased 60% sequentially to $215 million. |
|---|---|
| Mgmt Confidence | High confidence in delivering 1.1GW contracted capacity despite political shifts. |
| Demand Visibility | 1.1GW contracted; 1.9GW AMD reservation rights with 2027-2028 deadlines. |
| Order Book | 1.1GW contracted capacity; $1.8B expected annual run rate revenue. |
| Margin Trends | Adjusted EBITDA margin expanded to 57% from 25% last quarter. |
| Op. Leverage | EBITDA tripled on 60% revenue growth, showing massive fixed-cost leverage. |
| Pricing Power | AMD pricing reflects prevailing rates and development costs for future capacity. |
| Vol vs Price | Growth driven by 90MW additional capacity brought into billing this quarter. |
| Segment Growth | Co-location revenue up 60%; Bitcoin mining being exited by year-end. |
| New Clients | Secured AMD contract for 530MW initial capacity across five campuses. |
| Capex & Debt | $540M CAPEX; $440M Polaris acquisition; $1.7B total liquidity available. |
| Regulatory | Navigating ERCOT Bad Zero process; pending air permits for backup generators. |
| Commentary | Capital availability is the primary throttle for new AI infrastructure development. |
| New Launches | Developing 10.6 mile natural gas pipeline for on-site power at Pecos. |
Growth
Co-location revenue grew 60% sequentially to $215M; adjusted EBITDA tripled to $134M.
Outlook
Contracted portfolio expected to generate $1.8B annual revenue and $1.6B NOI when fully delivered.
Risks
Management used vague language regarding specific air permit timelines and potential Texas regulatory clawbacks.
The company's earnings call, NASDAQ: CORZ, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Core Scientific, Inc.: key numbers
- Share price
- $13.58Close, Nov 16
- Market cap
- $4.38B
- Shares outstanding
- 322.24MLatest SEC cover page
- Sector
- Crypto Assets
- Industry
- Finance ServicesSIC 6199
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Core Scientific, Inc.
All →Core Scientific Insider Todd M. Duchene Sells $125K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $12.39 to $12.70 a share (average $12.45) in 2 transactions, worth $125K in total on Nov 9, 2026. Shares held after the trade: 1,113,286 (-0.2%).
- Value
- $125K
- Shares
- 10,000
- Average price
- $12.45
- Holding change
- -0.2%
- Trade date
- Nov 9, 2026
Core Scientific Q3 2026 Results: Turns Profitable, Net Income $1.18B
Core Scientific reported a significant shift in its business model, with colocation revenue growing to $215.4 million for the quarter ended September 30, 2026, compared to $15.0 million in the prior year, driven by high-performance computing (HPC) initiatives. Despite a net loss of $324.4 million for the nine-month period, the company achieved a net income of $1.18 billion in the third quarter, primarily due to a $1.03 billion favorable change in the fair value of warrant liabilities.
- Key figure
- Net income $1.18B
Core Scientific Financial Results
Core Scientific reported third quarter 2026 financial results, highlighted by a nearly 60% sequential increase in colocation revenue to $215.4 million. The company achieved net income of $1.2 billion, primarily driven by a non-cash gain from the change in fair value of warrants, and significantly expanded its Adjusted EBITDA margins to 57%.
“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue. We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”
Adam Sullivan, Chief Executive Officer of Core Scientific
Core Scientific Insider Todd M. Duchene Sells $126K of Stock
Todd M. Duchene sold 9,900 shares of Core Scientific, Inc. at $12.78 a share, worth $126K in total on Nov 2, 2026. Shares held after the trade: 1,123,386 (-0.9%).
- Value
- $126K
- Shares
- 9,900
- Price
- $12.78
- Holding change
- -0.9%
- Trade date
- Nov 2, 2026
Core Scientific Insider Todd M. Duchene Sells $136K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.27 to $13.80 a share (average $13.56) in 2 transactions, worth $136K in total on Oct 26, 2026. Shares held after the trade: 1,133,286 (-0.5%).
- Value
- $136K
- Shares
- 10,000
- Average price
- $13.56
- Holding change
- -0.5%
- Trade date
- Oct 26, 2026
Core Scientific Insider Todd M. Duchene Sells $139K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.87 a share, worth $139K in total on Oct 19, 2026. Shares held after the trade: 1,143,286 (-0.9%).
- Value
- $139K
- Shares
- 10,000
- Price
- $13.87
- Holding change
- -0.9%
- Trade date
- Oct 19, 2026